SCHEMBL8153240

SCHEMBL8153240

Fc1ccc(C2CCCCCN2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
CYP2D6 P10635 2/20 0.50
CYP2C19 P33261 2/20 0.50
CHRNB2 P17787 2/20 0.50
CHRNA7 P36544 2/20 0.50
CHRNA4 P43681 2/20 0.50
POLB P06746 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2A6 P11509 1/20 0.50
CYP2C9 P11712 1/20 0.50
PARP1 P09874 4/20 0.43
LTA4H P09960 1/20 0.43
AURKA O14965 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
MKNK1 Q9BUB5 1/20 0.42
KCNH2 Q12809 1/20 0.41
ALDH1A1 P00352 1/20 0.38
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8541058 1.00 MEN1 (0.50) MEN1KMT2ACYP2D6CYP2C19CHRNB2
SCHEMBL938782 0.98 MEN1 (0.51) MEN1KMT2ACYP2D6CYP2C19CHRNB2
SCHEMBL938791 0.98 MEN1 (0.51) MEN1KMT2ACYP2D6CYP2C19CHRNB2
SCHEMBL19156 0.98 MEN1 (0.51) MEN1KMT2ACYP2D6CYP2C19CHRNB2
Hydrochloric Acid SCHEMBL1764829 0.96 MEN1 (0.50) MEN1KMT2ACYP2D6CYP2C19CHRNB2
SCHEMBL169110 0.92 CHRNB2 (0.50) MEN1KMT2ACYP2D6CYP2C19CHRNB2
SCHEMBL6179150 0.92 CHRNB2 (0.50) MEN1KMT2ACYP2D6CYP2C19CHRNB2
SCHEMBL169111 0.92 CHRNB2 (0.50) MEN1KMT2ACYP2D6CYP2C19CHRNB2
Hydrochloric Acid SCHEMBL3335329 0.90 CHRNB2 (0.49) MEN1KMT2ACYP2D6CYP2C19CHRNB2
Hydrochloric Acid SCHEMBL3335334 0.90 CHRNB2 (0.49) MEN1KMT2ACYP2D6CYP2C19CHRNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6093733-A FOR THE TREATMENT OR PREVENTION OF DISEASES THE TREATMENT OR PREVENTION OF WHICH IS MEDIATED BY MUSCARINIC RECEPTOR AGONISM; ALZHEIMER'S DISEASE PFIZER INC. 2000-07-25 US disclosed
EP-0705259-B1 PHENYRROLE DERIVATIVES AND THEIR USE AS DOPAMINE D3 ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1998-02-25 EP disclosed
EP-0705259-A1 PHENYRROLE DERIVATIVES AND THEIR USE AS DOPAMINE D3 ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1996-04-10 EP disclosed
WO-1995000508-A1 PHENYRROLE DERIVATIVES AND THEIR USE AS DOPAMINE D3 ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1995-01-05 WO disclosed